Cost effectiveness of preemptive therapy versus prophylaxis...

  • Main
  • 2020 / 07
  • Cost effectiveness of preemptive therapy versus prophylaxis...

Cost effectiveness of preemptive therapy versus prophylaxis in a randomized clinical trial for the prevention of CMV disease in seronegative liver transplant recipients with seropositive donors

Singh, Nina, Winston, Drew J, Razonable, Raymund R, Lyon, G Marshall, Silveira, Fernanda P, Wagener, Marilyn M, Limaye, Ajit P
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Clinical Infectious Diseases
DOI:
10.1093/cid/ciaa1051
Date:
July, 2020
File:
PDF, 564 KB
2020
Conversion to is in progress
Conversion to is failed